Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Anthea Ng"'
Autor:
Susan L. Heatley, Teresa Sadras, Chung H. Kok, Eva Nievergall, Kelly Quek, Phuong Dang, Barbara McClure, Nicola Venn, Sarah Moore, Jeffrey Suttle, Tamara Law, Anthea Ng, Walter Muskovic, Murray D. Norris, Tamas Revesz, Michael Osborn, Andrew S. Moore, Ram Suppiah, Chris Fraser, Frank Alvaro, Timothy P. Hughes, Charles G. Mullighan, Glenn M. Marshall, Luciano Dalla Pozza, David T. Yeung, Rosemary Sutton, Deborah L. White
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Externí odkaz:
https://doaj.org/article/2c2aa1289b7b4e80af648aea90e786bf
Autor:
Mascarenhas, Sandra S., Mittal, Rashmi Arun, Xuan Ting, Anthea Ng, Heng, Yan Zhen, Agarwal, Pratibha, Daniel, Lourdes Mary, Yang, Phey Hong
Publikováno v:
In Journal of the American Academy of Child & Adolescent Psychiatry October 2024 63(10) Supplement:S211-S212
Autor:
Beryl Lin, Adam Jaffe, Hiran Selvadurai, Kate Hardaker, Paul Robinson, Luciano Dalla-Pozza, Leanne Plush, Jamie McBride, Emma Coward, Geoffrey McCowage, Anthea Ng, Toby Trahair, Brendan Kennedy, John Widger
Publikováno v:
Pediatric Pulmonology
Background Respiratory viruses are a common cause of infection in immunosuppressed children undergoing cancer therapy. Pulmonary sequelae have been documented following respiratory viral infections (RVIs) in hematopoietic stem cell transplant (HSCT)
Autor:
Anuruddhika Dissanayake, Pauline Dalzell, Frank Alvaro, Luciano Dalla Pozza, Toby Trahair, Jodie E. Giles, Chelsea Mayoh, Anthea Ng, Tamara Law, Nicola C. Venn, Martin Schrappe, Tamas Revesz, Rosemary Sutton, Michelle Haber, Draga Barbaric, Monique L. den Boer, Rob Pieters, Murray D. Norris, Glenn M. Marshall, Judith M. Boer
Publikováno v:
British Journal of Haematology, 180(4), 550-562. Wiley-Blackwell Publishing Ltd
To prevent relapse, high risk paediatric acute lymphoblastic leukaemia (ALL) is treated very intensively. However, most patients who eventually relapse have standard or medium risk ALL with low minimal residual disease (MRD) levels. We analysed recur
Autor:
H. van den Berg, V de Haas, R. Maarten Egeler, Peter M. Hoogerbrugge, Gertjan J.L. Kaspers, Ram Suppiah, Frank Alvaro, E. S. J. M. de Bont, Rosemary Sutton, Murray D. Norris, L Dalla Pozza, Shamira Cross, Rob Pieters, H Mueller, T Revesz, Nicola C. Venn, Tamara Law, J. J. M. Van Dongen, Anthea Ng, V H J van der Velden, Michelle Haber, E van der Schoot, H A de Groot-Kruseman, Glenn M. Marshall, Marc Bierings
Publikováno v:
Leukemia, 27, 1497-503
Leukemia, 27(7), 1497-1503. Nature Publishing Group
Leukemia, 27, 7, pp. 1497-503
Marshall, G M, la Pozza, L, Sutton, R, Ng, A, de Groot-Kruseman, H, van der Velden, V H, Venn, N C, van den Berg, H, De Bont, E S J M, Egeler, R M, Hoogerbrugge, P M, Kaspers, G J L, Bierings, M B, van der Schoot, E, van Dongen, J, Law, T, Cross, S, Mueller, H, de Haas, V, Haber, M, Revesz, T, Alvaro, F, Suppiah, R, Norris, M D & Pieters, R 2013, ' High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation ', Leukemia, vol. 27, no. 7, pp. 1497-1503 . https://doi.org/10.1038/leu.2013.44
Leukemia, 27(7), 1497-1503. Nature Publishing Group
Leukemia, 27, 7, pp. 1497-503
Marshall, G M, la Pozza, L, Sutton, R, Ng, A, de Groot-Kruseman, H, van der Velden, V H, Venn, N C, van den Berg, H, De Bont, E S J M, Egeler, R M, Hoogerbrugge, P M, Kaspers, G J L, Bierings, M B, van der Schoot, E, van Dongen, J, Law, T, Cross, S, Mueller, H, de Haas, V, Haber, M, Revesz, T, Alvaro, F, Suppiah, R, Norris, M D & Pieters, R 2013, ' High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation ', Leukemia, vol. 27, no. 7, pp. 1497-1503 . https://doi.org/10.1038/leu.2013.44
Item does not contain fulltext Children with acute lymphoblastic leukemia (ALL) and high minimal residual disease (MRD) levels after initial chemotherapy have a poor clinical outcome. In this prospective, single arm, Phase 2 trial, 111 Dutch and Aust
Autor:
John Bui, Kristina Prelog, Jacqui Zhu, Aditya Kumar Gupta, Luciano Dalla-Pozza, Michael P. Jones, Anthea Ng
Publikováno v:
Pediatric hematology and oncology. 33(6)
Patients with familial/heritable retinoblastoma (RB) are at increased risk of developing second malignancies throughout life, including a pineoblastoma (trilateral RB [TRB]) in early childhood. Current guidelines recommend regular surveillance brain
Autor:
Vasa Curcin, Azeem Majeed, Christopher Millett, F.L. Hamilton, Josip Car, Anthea Ng, Alex Bottle, Mariam Molokhia, Utz Johann Pape, Eszter P. Vamos
Publikováno v:
Canadian Medical Association Journal. 183:E809-E816
Background: Not enough is known about the association between practice size and clinical outcomes in primary care. We examined this association between 1997 and 2005, in addition to the impact of the Quality and Outcomes Framework, a pay-for-performa
Autor:
Azeem Majeed, Alex Bottle, Mariam Molokhia, Vasa Curcin, Sonia Saxena, Christopher Millett, Anthea Ng
Publikováno v:
Journal of the Royal Society of Medicine. 102:369-377
Summary Objective To examine the impact of the Quality and Outcomes Framework, a major pay-for-performance incentive introduced in the UK during 2004, on diabetes management in patients with and without co-morbidity. Design Cohort study comparing act
Publikováno v:
Journal of Public Health. 29:413-419
The National Health Service (NHS) has invested substantially in recent years to reduce variations in health care for chronic conditions such as diabetes. We examined trends in the management of diabetes in England between socio-economic and ethnic gr
Autor:
Luciano Dalla Pozza, Deborah L. White, Michael Osborn, Timothy P. Hughes, Eva Nievergall, Sarah Moore, Frank Alvaro, Teresa Sadras, Phuong Dang, Susan L. Heatley, Chung H. Kok, Tamara Law, Chris Fraser, Charles G. Mullighan, Murray D. Norris, Tamas Revesz, Kelly Quek, Nicola C. Venn, Rosemary Sutton, Glenn M. Marshall, Anthea Ng
Publikováno v:
Blood. 126:1419-1419
Introduction: While remission rates for childhood acute lymphoblastic leukemia (ALL) now exceed 80%, relapsed ALL remains the leading cause of non-traumatic death in children. Recently, a high-risk group of B-progenitor ALL patients has been identifi